AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 8,400.00
+180.00 (2.19%)
Oct 10, 2025, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 234.52 billion as of October 10, 2025. Its market cap has decreased by -0.99% in one year.
Market Cap
234.52B
Enterprise Value
220.44B
Revenue
3.11B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,400.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 234.52B, a decrease of -44.60%. That is a compound annual growth rate of -8.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 229.49B | 34.02% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | 563.64B | 49.70% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |